Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats - PubMed (original) (raw)
. 1995 Dec 1;55(23 Suppl):5874s-5880s.
Affiliations
- PMID: 7493363
Enhanced radioimmunotargeting of 125I-labeled L6-biotin monoclonal antibody (MAb) by combining preload of cold L6 MAb and subsequent immunoadsorption in rats
M Garkavij et al. Cancer Res. 1995.
Abstract
The present study investigates whether tumor:normal tissue uptake ratios of radiolabeled monoclonal antibodies can be further improved by a combination of extracorporeal immunoadsorption (ECIA) and preload with unlabeled idiotypic monoclonal antibody. Athymic rats, heterotransplanted with human lung carcinoma under the kidney capsule (SR tumor) and i.m. (IM tumor), were divided into four study groups: controls, ECIA, preload, and combined preload+ECIA. The preload+ECIA procedure reduced the whole-body and plasma activity by 48 and 89%, respectively. After such combined procedure, the uptake of 125I-labeled L6-biotin in SR tumors was unchanged, while the uptake in normal tissues was considerably reduced. Tumor (T):bone marrow ratio was then increased by 17.5 times (after ECIA) and by 4.5 times (24 h after ECIA). Similar enhancements were achieved for T:liver and T:kidney ratios. For the IM tumors, the ratios were not as high as for SR tumors. The effects on T:normal ratios of preload+ECIA in combination were synergistic. The combined procedure resulted both in an increased uptake and prolonged persistence of 125I-labeled L6-biotin in the SR tumors and also in a reduction of corresponding uptake values in organs critical for radiation.
Similar articles
- Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption.
Garkavij M, Tennvall J, Ohlsson T, Lindgren L, Hindorf C, Sjögren HO, Strand SE. Garkavij M, et al. Clin Cancer Res. 1999 Oct;5(10 Suppl):3059s-3064s. Clin Cancer Res. 1999. PMID: 10541344 - Improving radioimmunotargeting of tumors: the impact of preloading unlabeled L6 monoclonal antibody on the biodistribution of 125I-L6 in rats.
Garkavij M, Tennvall J, Strand SE, Norrgren K, Nilsson R, Sjögren HO. Garkavij M, et al. J Nucl Biol Med (1991). 1994 Dec;38(4):594-600. J Nucl Biol Med (1991). 1994. PMID: 7786923 - Extracorporeal whole-blood immunoadsorption enhances radioimmunotargeting of iodine-125-labeled BR96-biotin monoclonal antibody.
Garkavij M, Tennvall J, Strand SE, Sjögren HO, JianQing C, Nilsson R, Isaksson M. Garkavij M, et al. J Nucl Med. 1997 Jun;38(6):895-901. J Nucl Med. 1997. PMID: 9189138 - Improving radioimmonotargeting of tumors. Variation in the amount of L6 MAb administered, combined with an immunoadsorption system (ECIA).
Garkavij M, Tennvall J, Strand SE, Norrgren K, Nilsson R, Lindgren L, Sjögren HO. Garkavij M, et al. Acta Oncol. 1993;32(7-8):853-9. doi: 10.3109/02841869309096146. Acta Oncol. 1993. PMID: 8305236
Cited by
- Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer.
Fu F, Yang X, Zheng M, Zhao Q, Zhang K, Li Z, Zhang H, Zhang S. Fu F, et al. Front Mol Biosci. 2020 Aug 18;7:202. doi: 10.3389/fmolb.2020.00202. eCollection 2020. Front Mol Biosci. 2020. PMID: 33015133 Free PMC article. Review. - Emerging trends for radioimmunotherapy in solid tumors.
Jain M, Gupta S, Kaur S, Ponnusamy MP, Batra SK. Jain M, et al. Cancer Biother Radiopharm. 2013 Nov;28(9):639-50. doi: 10.1089/cbr.2013.1523. Epub 2013 Jul 11. Cancer Biother Radiopharm. 2013. PMID: 23844555 Free PMC article. Review. - The L6 membrane proteins--a new four-transmembrane superfamily.
Wright MD, Ni J, Rudy GB. Wright MD, et al. Protein Sci. 2000 Aug;9(8):1594-600. doi: 10.1110/ps.9.8.1594. Protein Sci. 2000. PMID: 10975581 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials